Skip to main content
Premium Trial:

Request an Annual Quote

Precision Cancer Consortium Launches With Bayer, GSK, Roche, Novartis as Founding Members

NEW YORK — The Precision Cancer Consortium (PCC), a group of biopharmaceutical firms collaborating to increase access to genomic testing in oncology, said on Tuesday that it has launched with Bayer, GlaxoSmithKline, Novartis, and Roche as its inaugural members.

The PCC said its focus is on increasing patient access to precision diagnostics based on next-generation sequencing and other genomic technologies in both routine care and clinical trials.

To do so, the group plans to remove barriers to access and increase educational awareness of the value of genomic testing for healthcare stakeholders including patients, providers, and healthcare systems. It also aims to improve efficiencies in genomic biomarker testing in clinical studies.

The PCC said it is open to additional members and will not endorse or promote specific diagnostic or therapeutic products or services.

"With cancer, the earlier patients are diagnosed and begin treatment, the better their outcomes tend to be," Espen Walker, integrated strategy leader at Roche Foundation Medicine, who is chair of the PCC, said in a statement. "Precision diagnostics, including comprehensive genomic testing, are an important part of developing treatment plans that can help patients. The PCC is focused on addressing these barriers across the cancer ecosystem with the aim of improving outcomes for patients."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.